Copyright Reports & Markets. All rights reserved.

Global Human Organs-on-Chips Model Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Organs-on-Chips Model Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Multi Organ Model
    • 1.3.3 Single Organ Model
    • 1.3.4 Human Tissue Model
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Organs-on-Chips Model Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Drug Development
    • 1.4.3 Disease Modeling
    • 1.4.4 Personalized Medicine
    • 1.4.5 Others
  • 1.5 Global Human Organs-on-Chips Model Market Size & Forecast
    • 1.5.1 Global Human Organs-on-Chips Model Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Human Organs-on-Chips Model Sales Quantity (2021-2032)
    • 1.5.3 Global Human Organs-on-Chips Model Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Emulate
    • 2.1.1 Emulate Details
    • 2.1.2 Emulate Major Business
    • 2.1.3 Emulate Human Organs-on-Chips Model Product and Services
    • 2.1.4 Emulate Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Emulate Recent Developments/Updates
  • 2.2 Mimetas
    • 2.2.1 Mimetas Details
    • 2.2.2 Mimetas Major Business
    • 2.2.3 Mimetas Human Organs-on-Chips Model Product and Services
    • 2.2.4 Mimetas Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Mimetas Recent Developments/Updates
  • 2.3 Cherry Biotech
    • 2.3.1 Cherry Biotech Details
    • 2.3.2 Cherry Biotech Major Business
    • 2.3.3 Cherry Biotech Human Organs-on-Chips Model Product and Services
    • 2.3.4 Cherry Biotech Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Cherry Biotech Recent Developments/Updates
  • 2.4 CN Bio Innovations
    • 2.4.1 CN Bio Innovations Details
    • 2.4.2 CN Bio Innovations Major Business
    • 2.4.3 CN Bio Innovations Human Organs-on-Chips Model Product and Services
    • 2.4.4 CN Bio Innovations Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 CN Bio Innovations Recent Developments/Updates
  • 2.5 Nortis
    • 2.5.1 Nortis Details
    • 2.5.2 Nortis Major Business
    • 2.5.3 Nortis Human Organs-on-Chips Model Product and Services
    • 2.5.4 Nortis Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Nortis Recent Developments/Updates
  • 2.6 TissUse
    • 2.6.1 TissUse Details
    • 2.6.2 TissUse Major Business
    • 2.6.3 TissUse Human Organs-on-Chips Model Product and Services
    • 2.6.4 TissUse Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 TissUse Recent Developments/Updates
  • 2.7 BiomimX
    • 2.7.1 BiomimX Details
    • 2.7.2 BiomimX Major Business
    • 2.7.3 BiomimX Human Organs-on-Chips Model Product and Services
    • 2.7.4 BiomimX Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 BiomimX Recent Developments/Updates
  • 2.8 Altis Biosystems
    • 2.8.1 Altis Biosystems Details
    • 2.8.2 Altis Biosystems Major Business
    • 2.8.3 Altis Biosystems Human Organs-on-Chips Model Product and Services
    • 2.8.4 Altis Biosystems Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Altis Biosystems Recent Developments/Updates
  • 2.9 Ananda Devices
    • 2.9.1 Ananda Devices Details
    • 2.9.2 Ananda Devices Major Business
    • 2.9.3 Ananda Devices Human Organs-on-Chips Model Product and Services
    • 2.9.4 Ananda Devices Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Ananda Devices Recent Developments/Updates
  • 2.10 Netri
    • 2.10.1 Netri Details
    • 2.10.2 Netri Major Business
    • 2.10.3 Netri Human Organs-on-Chips Model Product and Services
    • 2.10.4 Netri Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Netri Recent Developments/Updates
  • 2.11 React4life
    • 2.11.1 React4life Details
    • 2.11.2 React4life Major Business
    • 2.11.3 React4life Human Organs-on-Chips Model Product and Services
    • 2.11.4 React4life Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 React4life Recent Developments/Updates
  • 2.12 SynVivo
    • 2.12.1 SynVivo Details
    • 2.12.2 SynVivo Major Business
    • 2.12.3 SynVivo Human Organs-on-Chips Model Product and Services
    • 2.12.4 SynVivo Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 SynVivo Recent Developments/Updates
  • 2.13 Draper Laboratory
    • 2.13.1 Draper Laboratory Details
    • 2.13.2 Draper Laboratory Major Business
    • 2.13.3 Draper Laboratory Human Organs-on-Chips Model Product and Services
    • 2.13.4 Draper Laboratory Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Draper Laboratory Recent Developments/Updates
  • 2.14 AlveoliX
    • 2.14.1 AlveoliX Details
    • 2.14.2 AlveoliX Major Business
    • 2.14.3 AlveoliX Human Organs-on-Chips Model Product and Services
    • 2.14.4 AlveoliX Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 AlveoliX Recent Developments/Updates
  • 2.15 TNO
    • 2.15.1 TNO Details
    • 2.15.2 TNO Major Business
    • 2.15.3 TNO Human Organs-on-Chips Model Product and Services
    • 2.15.4 TNO Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 TNO Recent Developments/Updates
  • 2.16 Hesperos
    • 2.16.1 Hesperos Details
    • 2.16.2 Hesperos Major Business
    • 2.16.3 Hesperos Human Organs-on-Chips Model Product and Services
    • 2.16.4 Hesperos Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Hesperos Recent Developments/Updates
  • 2.17 Abance Biotechnology
    • 2.17.1 Abance Biotechnology Details
    • 2.17.2 Abance Biotechnology Major Business
    • 2.17.3 Abance Biotechnology Human Organs-on-Chips Model Product and Services
    • 2.17.4 Abance Biotechnology Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Abance Biotechnology Recent Developments/Updates
  • 2.18 Beijing Daxiang Biotech
    • 2.18.1 Beijing Daxiang Biotech Details
    • 2.18.2 Beijing Daxiang Biotech Major Business
    • 2.18.3 Beijing Daxiang Biotech Human Organs-on-Chips Model Product and Services
    • 2.18.4 Beijing Daxiang Biotech Human Organs-on-Chips Model Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Beijing Daxiang Biotech Recent Developments/Updates

3 Competitive Environment: Human Organs-on-Chips Model by Manufacturer

  • 3.1 Global Human Organs-on-Chips Model Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Human Organs-on-Chips Model Revenue by Manufacturer (2021-2026)
  • 3.3 Global Human Organs-on-Chips Model Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Human Organs-on-Chips Model by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Human Organs-on-Chips Model Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Human Organs-on-Chips Model Manufacturer Market Share in 2025
  • 3.5 Human Organs-on-Chips Model Market: Overall Company Footprint Analysis
    • 3.5.1 Human Organs-on-Chips Model Market: Region Footprint
    • 3.5.2 Human Organs-on-Chips Model Market: Company Product Type Footprint
    • 3.5.3 Human Organs-on-Chips Model Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Organs-on-Chips Model Market Size by Region
    • 4.1.1 Global Human Organs-on-Chips Model Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Human Organs-on-Chips Model Consumption Value by Region (2021-2032)
    • 4.1.3 Global Human Organs-on-Chips Model Average Price by Region (2021-2032)
  • 4.2 North America Human Organs-on-Chips Model Consumption Value (2021-2032)
  • 4.3 Europe Human Organs-on-Chips Model Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Human Organs-on-Chips Model Consumption Value (2021-2032)
  • 4.5 South America Human Organs-on-Chips Model Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Human Organs-on-Chips Model Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Human Organs-on-Chips Model Sales Quantity by Type (2021-2032)
  • 5.2 Global Human Organs-on-Chips Model Consumption Value by Type (2021-2032)
  • 5.3 Global Human Organs-on-Chips Model Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Human Organs-on-Chips Model Sales Quantity by Application (2021-2032)
  • 6.2 Global Human Organs-on-Chips Model Consumption Value by Application (2021-2032)
  • 6.3 Global Human Organs-on-Chips Model Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Human Organs-on-Chips Model Sales Quantity by Type (2021-2032)
  • 7.2 North America Human Organs-on-Chips Model Sales Quantity by Application (2021-2032)
  • 7.3 North America Human Organs-on-Chips Model Market Size by Country
    • 7.3.1 North America Human Organs-on-Chips Model Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Human Organs-on-Chips Model Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Human Organs-on-Chips Model Sales Quantity by Type (2021-2032)
  • 8.2 Europe Human Organs-on-Chips Model Sales Quantity by Application (2021-2032)
  • 8.3 Europe Human Organs-on-Chips Model Market Size by Country
    • 8.3.1 Europe Human Organs-on-Chips Model Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Human Organs-on-Chips Model Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Organs-on-Chips Model Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Human Organs-on-Chips Model Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Human Organs-on-Chips Model Market Size by Region
    • 9.3.1 Asia-Pacific Human Organs-on-Chips Model Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Human Organs-on-Chips Model Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Human Organs-on-Chips Model Sales Quantity by Type (2021-2032)
  • 10.2 South America Human Organs-on-Chips Model Sales Quantity by Application (2021-2032)
  • 10.3 South America Human Organs-on-Chips Model Market Size by Country
    • 10.3.1 South America Human Organs-on-Chips Model Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Human Organs-on-Chips Model Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Organs-on-Chips Model Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Human Organs-on-Chips Model Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Human Organs-on-Chips Model Market Size by Country
    • 11.3.1 Middle East & Africa Human Organs-on-Chips Model Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Human Organs-on-Chips Model Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Human Organs-on-Chips Model Market Drivers
  • 12.2 Human Organs-on-Chips Model Market Restraints
  • 12.3 Human Organs-on-Chips Model Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Organs-on-Chips Model and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Organs-on-Chips Model
  • 13.3 Human Organs-on-Chips Model Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Organs-on-Chips Model Typical Distributors
  • 14.3 Human Organs-on-Chips Model Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Organs-on-Chips Model market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    We have developed a range of validated Organ-Chip models that enable researchers to more closely emulate human biology by combining human cell sourcing, an organ-specific microenvironment, and tissue-relevant mechanical forces.
    This report is a detailed and comprehensive analysis for global Human Organs-on-Chips Model market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Organs-on-Chips Model market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Organs-on-Chips Model market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Organs-on-Chips Model market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Organs-on-Chips Model market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Organs-on-Chips Model
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Organs-on-Chips Model market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emulate, Mimetas, Cherry Biotech, CN Bio Innovations, Nortis, TissUse, BiomimX, Altis Biosystems, Ananda Devices, Netri, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Human Organs-on-Chips Model market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Multi Organ Model
    Single Organ Model
    Human Tissue Model
    Market segment by Application
    Drug Development
    Disease Modeling
    Personalized Medicine
    Others
    Major players covered
    Emulate
    Mimetas
    Cherry Biotech
    CN Bio Innovations
    Nortis
    TissUse
    BiomimX
    Altis Biosystems
    Ananda Devices
    Netri
    React4life
    SynVivo
    Draper Laboratory
    AlveoliX
    TNO
    Hesperos
    Abance Biotechnology
    Beijing Daxiang Biotech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Human Organs-on-Chips Model product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Human Organs-on-Chips Model, with price, sales quantity, revenue, and global market share of Human Organs-on-Chips Model from 2021 to 2026.
    Chapter 3, the Human Organs-on-Chips Model competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Human Organs-on-Chips Model breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Human Organs-on-Chips Model market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Human Organs-on-Chips Model.
    Chapter 14 and 15, to describe Human Organs-on-Chips Model sales channel, distributors, customers, research findings and conclusion.

    Buy now